Amodip-V Plus 10/160/12.5mg Tablets — Amlodipine + Valsartan + HCTZ
Amodip-V Plus 10/160/12.5mg combines Amlodipine 10mg (CCB), Valsartan 160mg (ARB), and Hydrochlorothiazide 12.5mg (diuretic) for triple-mechanism hypertension control. For patients not controlled on dual CCB+ARB therapy. Regular electrolyte monitoring required. Prescription required.
Pay in 3 Installments of
Rs.
210
Amodip-v Plus 10/160/12.5mg Tablets — Amlodipine + Valsartan + Hctz
Description
What is Amodip-V Plus 10/160/12.5mg?
Amodip-V Plus Tablets 10/160/12.5mg contain a fixed-dose triple combination of Amlodipine 10mg (CCB), Valsartan 160mg (ARB), and Hydrochlorothiazide 12.5mg (HCTZ — thiazide diuretic). This three-agent regimen is intended for patients with hypertension not adequately controlled on dual therapy (CCB+ARB). The addition of HCTZ targets a third mechanism — sodium and water excretion — to further lower blood pressure. Prescription required; specialist oversight recommended.
How Does Amodip-V Plus Work?
Amlodipine 10mg blocks L-type calcium channels in vascular smooth muscle → arterial vasodilation → reduced peripheral resistance. Valsartan 160mg blocks AT1 angiotensin II receptors → prevents RAAS-mediated vasoconstriction and aldosterone release → lower blood pressure and vascular remodelling. Hydrochlorothiazide 12.5mg inhibits sodium reabsorption in the distal renal tubule → natriuresis → reduced plasma volume → complementary blood pressure reduction. All three mechanisms act synergistically for comprehensive antihypertensive control.
Uses of Amodip-V Plus 10/160/12.5mg
Indicated for: resistant or difficult-to-control hypertension in adults who are already on Amodip-V (dual CCB+ARB) at full doses but have not reached blood pressure targets. Reduces risk of stroke, myocardial infarction, heart failure, and hypertensive nephropathy. Consult your cardiologist — prescription required.
Dosage & Administration
Adults: One tablet once daily with water, with or without food. Take at the same time each day. Do not crush or chew. Regular monitoring of blood pressure, renal function, electrolytes (sodium, potassium, creatinine) and uric acid is essential on triple therapy. Browse anti-hypertensive medicines for related products.
Side Effects
From Amlodipine: peripheral oedema, headache, flushing. From Valsartan: hyperkalaemia, dizziness, hypotension. From HCTZ: hypokalaemia (note: antagonises Valsartan's hyperkalaemic tendency), hyponatraemia, hyperuricaemia (gout exacerbation), impaired glucose tolerance, photosensitivity, postural hypotension. Triple therapy increases risk of electrolyte imbalances — monitoring is mandatory.
Precautions
Contraindicated: pregnancy (ARB + HCTZ both contraindicated), anuria, severe renal/hepatic impairment, hyponatraemia. Caution with: lithium (HCTZ raises lithium levels), NSAIDs, allopurinol. Check uric acid before starting — gout patients should avoid HCTZ or use with allopurinol under specialist guidance. Monitor blood pressure, electrolytes and renal function regularly. This is a prescription-only medicine requiring specialist supervision. See our general medicines collection.
Frequently Asked Questions
Q: When is Amodip-V Plus 10/160/12.5mg prescribed?
A: It is prescribed for hypertension that is not controlled on dual therapy (CCB+ARB alone). The diuretic adds a third complementary mechanism to achieve target blood pressure.
Q: Does HCTZ in Amodip-V Plus cause low potassium?
A: Yes, HCTZ can lower potassium (hypokalaemia). This is partially offset by Valsartan's potassium-sparing tendency. Regular blood potassium monitoring is required.
Q: Can I take Amodip-V Plus if I have diabetes?
A: Use with caution. HCTZ can impair glucose tolerance. Your doctor will assess whether triple therapy benefits outweigh this metabolic risk in your case.
Usage & Benefits
- Triple-mechanism therapy: CCB + ARB + thiazide diuretic in one tablet
- Amlodipine 10mg provides maximal calcium channel blockade for arterial dilation
- Valsartan 160mg blocks RAAS axis for additional BP reduction and organ protection
- HCTZ 12.5mg reduces plasma volume via natriuresis — third independent mechanism
- Convenient once-daily triple combination for treatment-resistant hypertension
- Reduces risk of stroke, myocardial infarction and hypertensive nephropathy
How To Use
Adults: One tablet (10/160/12.5mg) once daily with water, with or without food. Take at the same time each day. Do not crush or chew. Mandatory: monitor blood pressure, electrolytes (sodium, potassium), renal function (creatinine, eGFR) and uric acid at baseline and regularly during therapy. Prescription required — specialist supervision essential.
FAQs
When is Amodip-V Plus 10/160/12.5mg prescribed?
When hypertension is not adequately controlled on dual CCB+ARB therapy (Amodip-V). The diuretic adds a third complementary mechanism — natriuresis — to achieve target BP.
Does HCTZ cause low potassium in this combination?
HCTZ can lower potassium; Valsartan tends to raise it. The net effect varies — mandatory periodic monitoring of blood potassium is required on triple therapy.
Can patients with gout take Amodip-V Plus?
HCTZ can raise uric acid and precipitate gout attacks. Gout patients should discuss this risk carefully with their doctor before starting, and monitor uric acid levels.
Dermatologist Recommended
Healer's Pharma Minoxidil 5% + Finasteride 0.25% Hair Regrowth Spray
0.25% Finasteride Topical Hair Loss Spray by Healer's Pharma
